drugset / Trial / NCT01375374

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

NCT01375374

Phase 3 Terminated 11 enrolled UCB Pharma
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the trial is to investigate whether changes in lipids and hormonal parameters can be observed in blood when Carbamazepine treatment is replaced with Lacosamide treatment, while Levetiracetam treatment remains unchanged.

Timeline

Start
2011-07
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified 400 mg
Background Levetiracetam Other / unclassified

Indications